Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology

被引:59
作者
Dao, Jennifer H. [1 ]
Kurzeja, Robert J. M. [1 ]
Morachis, Jose M. [1 ]
Veith, Henrike [1 ]
Lewis, Jeffery [1 ]
Yu, Violeta [1 ]
Tegley, Christopher M. [1 ]
Tagari, Philip [1 ]
机构
[1] Amgen Inc, HTS Mol Pharmacol, Thousand Oaks, CA 91320 USA
关键词
2-Oxoglutarate; HIF; Non-heme iron; Oxygen; PHD2; Prolyl hydroxylase; Von Hippel-Lindau protein vHL; PROLINE HYDROXYLATION; HIF-ALPHA; ASCORBATE; 4-HYDROXYLASE; PATHWAY; COMPLEX; IRON; PROLYL-HYDROXYLASE-2; DESFERRIOXAMINE; HYDROXYPROLINE;
D O I
10.1016/j.ab.2008.09.052
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The human hypoxia-inducible factor prolyl hydroxylases 1, 2, and 3 (HIF-PHD1, -2, and -3) are thought to act as proximal sensors of cellular hypoxia by virtue of their mechanism-based dependence on molecular oxygen. These 2-oxoglutarate (2-OG) and non-heme iron-dependent oxygenases constitutively hydroxylate HIF, resulting in high-affinity binding to Von Hippel-Lindau protein (pVHL). Some reported affinities for the HIF-PHDs for 2-OG and iron approach the estimated physiological concentrations for these cofactors, suggesting that the system as described is not catalytically optimal. Here we report the enzymatic characterization of full-length recombinant human HIF-PHD2 using a novel and sensitive catalytic assay. We demonstrated submicromolar affinities for 2-OG and ferrous iron and HIF-PHD2 K., values for oxygen that are greater than atmospheric oxygen levels, suggesting that molecular oxygen is indeed the key regulator of this pathway. In addition, we observed enhancement of HIF-PHD2 catalytic activity in the presence of ascorbic acid with only minor modifications of HIF-PHD2 requirements for 2-OG, and a detailed pH Study demonstrated optimal HIF-PHD2 catalytic activity at pH 6.0. Lastly, we used this sensitive and facile assay to rapidly perform a large high-throughput screen of a chemical library to Successfully identify and characterize novel 2-OG competitive inhibitors of HIF-PHD2. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:213 / 223
页数:11
相关论文
共 37 条
  • [1] Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor
    Appelhoff, RJ
    Tian, YM
    Raval, RR
    Turley, H
    Harris, AL
    Pugh, CW
    Ratcliffe, PJ
    Gleadle, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) : 38458 - 38465
  • [2] HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia
    Berra, E
    Benizri, E
    Ginouvès, A
    Volmat, V
    Roux, D
    Pouysségur, J
    [J]. EMBO JOURNAL, 2003, 22 (16) : 4082 - 4090
  • [3] A conserved family of prolyl-4-hydroxylases that modify HIF
    Bruick, RK
    McKnight, SL
    [J]. SCIENCE, 2001, 294 (5545) : 1337 - 1340
  • [4] A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases
    Cho, H
    Park, H
    Yang, EG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 337 (01) : 275 - 280
  • [5] NOVEL INHIBITORS OF PROLYL 4-HYDROXYLASE .3. INHIBITION BY THE SUBSTRATE-ANALOG N-OXALOGLYCINE AND ITS DERIVATIVES
    CUNLIFFE, CJ
    FRANKLIN, TJ
    HALES, NJ
    HILL, GB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (14) : 2652 - 2658
  • [6] PROLYL 4-HYDROXYLASE ACTIVITY IN RELATION TO THE OXIDATION-STATE OF ENZYME-BOUND IRON - THE ROLE OF ASCORBATE IN PEPTIDYL PROLINE HYDROXYLATION
    DEJONG, L
    ALBRACHT, SPJ
    KEMP, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 704 (02) : 326 - 332
  • [7] Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay
    Ehrismann, Dominic
    Flashman, Emily
    Genn, David N.
    Mathioudakis, Nicolas
    Hewitson, Kirsty S.
    Ratcliffe, Peter J.
    Schofield, Christopher J.
    [J]. BIOCHEMICAL JOURNAL, 2007, 401 : 227 - 234
  • [8] ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405
  • [9] C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
    Epstein, ACR
    Gleadle, JM
    McNeill, LA
    Hewitson, KS
    O'Rourke, J
    Mole, DR
    Mukherji, M
    Metzen, E
    Wilson, MI
    Dhanda, A
    Tian, YM
    Masson, N
    Hamilton, DL
    Jaakkola, P
    Barstead, R
    Hodgkin, J
    Maxwell, PH
    Pugh, CW
    Schofield, CJ
    Ratcliffe, PJ
    [J]. CELL, 2001, 107 (01) : 43 - 54
  • [10] Modulating the hypoxia-inducible factor signaling pathway: Applications from cardiovascular disease to cancer
    Hewitson, KS
    McNeill, LA
    Schofield, CJ
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (08) : 821 - 833